Concept
Cyproterone acetate
Concepts associés (47)
Algestone acetophenide
Algestone acetophenide, also known more commonly as dihydroxyprogesterone acetophenide (DHPA) and sold under the brand names Perlutal and Topasel among others, is a progestin medication which is used in combination with an estrogen as a form of long-lasting injectable birth control. It has also been used alone, but is no longer available as a standalone medication. DHPA is not active by mouth and is given once a month by injection into muscle. Side effects of DHPA are similar to those of other progestins.
Hydroxyprogesterone acetate
Hydroxyprogesterone acetate (OHPA), sold under the brand name Prodox, is an orally active progestin related to hydroxyprogesterone caproate (OHPC) which has been used in clinical and veterinary medicine. It has reportedly also been used in birth control pills. OHPA is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological target of progestogens like progesterone. OHPA was discovered in 1953 and was introduced for medical use in 1956.
Steroidogenesis inhibitor
A steroidogenesis inhibitor, also known as a steroid biosynthesis inhibitor, is a type of drug which inhibits one or more of the enzymes that are involved in the process of steroidogenesis, the biosynthesis of endogenous steroids and steroid hormones. They may inhibit the production of cholesterol and other sterols, sex steroids such as androgens, estrogens, and progestogens, corticosteroids such as glucocorticoids and mineralocorticoids, and neurosteroids.
Ethinylestradiol sulfonate
Ethinylestradiol sulfonate (EES), sold under the brand names Deposiston and Turisteron among others, is an estrogen medication which has been used in birth control pills for women and in the treatment of prostate cancer in men. It has also been investigated in the treatment of breast cancer in women. The medication was combined with norethisterone acetate in birth control pills. EES is taken by mouth once per week. Side effects of EES in men include breast tenderness, gynecomastia, feminization, sexual dysfunction, and cardiovascular complications, among others.
Estradiol-containing birth control pill
Combined birth control pills that contain natural estradiol or an estradiol ester (e.g., estradiol valerate) include: Estradiol valerate and cyproterone acetate (brand name Femilar) – introduced in Finland (only) in 1993 Estradiol valerate and dienogest (brand names Qlaira, Natazia) – introduced in Europe in 2009 and the () in 2010 Estradiol and nomegestrol acetate (brand name Zoely) – introduced in Europe in 2011 Estradiol, mainly as esters including estradiol valerate, estradiol cypionate, and estradiol enanthate, is also the exclusive estrogen used in combined injectable contraceptives.
Mammoplasia
Mammoplasia is the normal or spontaneous enlargement of human breasts. Mammoplasia occurs normally during puberty and pregnancy in women, as well as during certain periods of the menstrual cycle. When it occurs in males, it is called gynecomastia and is considered to be pathological. When it occurs in females and is extremely excessive, it is called macromastia (also known as gigantomastia or breast hypertrophy) and is similarly considered to be pathological.
Contraception masculine
alt=Anneau contraceptif testiculaire Andro-switch|vignette|Anneau contraceptif testiculaire Andro-switch La contraception utilisée par les hommes vise les spermatozoïdes, leur production (par une atteinte à la spermatogenèse (par voie hormonale, chimique ou thermique) ou leur acheminement (par voie chirurgicale : la vasectomie, obstruction mécanique : le préservatif, ou encore comportemental : la méthode du retrait). Il reste que la diversité des contraceptions masculines est mal connue, même des praticiens prescripteurs.